PHASE II
Clinical trials for PHASE II explained in plain language.
Never miss a new study
Get alerted when new PHASE II trials appear
Sign up with your email to follow new studies for PHASE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare kidney cancer: experimental drug targets aggressive tumors
Disease control Not yet recruitingThis study tests whether the drug sacituzumab tirumotecan can control advanced or spreading SMARCB1-deficient renal medullary carcinoma, a rare and aggressive kidney cancer. It is for 20 people whose cancer has worsened after at least one prior treatment. The main goal is to chec…
Matched conditions: PHASE II
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:01 UTC
-
New drug trial aims to tame rare blood cancers
Disease control Not yet recruitingThis study tests a drug called imetelstat in 30 adults with certain blood cancers (MDS/MPN). The goal is to see if it can help control the disease. The main focus is on safety and side effects. The study is not yet open for participants.
Matched conditions: PHASE II
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC